BioBridgeXAll companies

Quince Therapeutics, Inc.

Biotechnology company · South San Francisco, California, United States · Nasdaq: QNCX

Quince Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2012. Its shares trade on Nasdaq under the ticker QNCX. It has reported private securities offerings to the US SEC, most recently $115 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Quince Therapeutics at a glance

Typebiotechnology company
HeadquartersSouth San Francisco, California, United States
Earliest incorporation on record2012
Stock listingNasdaq: QNCX
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1662774

What does Quince Therapeutics do?

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $114.7 million sold (2026).

Frequently asked questions about Quince Therapeutics

Where is Quince Therapeutics headquartered?

Quince Therapeutics, Inc. is headquartered in South San Francisco, California, United States.

What does Quince Therapeutics do?

Quince Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Quince Therapeutics a public company?

Yes. Quince Therapeutics, Inc. trades on Nasdaq under the ticker QNCX.

When was Quince Therapeutics founded?

The earliest incorporation on record for Quince Therapeutics, Inc. is in 2012, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.